Anaerotruncus colihominis 277 is an anaerobe, Gram-positive, rod-shaped bacterium that forms irregular colonies and was isolated from human feces, autistic child.
Gram-positive rod-shaped colony-forming anaerobe genome sequence 16S sequence Bacteria| @ref 20215 |
|
|
| Domain Bacteria |
| Phylum Bacillota |
| Class Clostridia |
| Order Eubacteriales |
| Family Oscillospiraceae |
| Genus Anaerotruncus |
| Species Anaerotruncus colihominis |
| Full scientific name Anaerotruncus colihominis Lawson et al. 2004 |
| BacDive ID | Other strains from Anaerotruncus colihominis (4) | Type strain |
|---|---|---|
| 131106 | A. colihominis JM4-15, DSM 28734 | |
| 156776 | A. colihominis CCUG 65088 | |
| 157144 | A. colihominis CCUG 69734 | |
| 163983 | A. colihominis JCM 31255 |
| @ref | Colony size | Colony color | Colony shape | Incubation period | Medium used | Hemolysis ability | |
|---|---|---|---|---|---|---|---|
| 26285 | 2-3 mm | grey | irregular | 2 days | Brucella blood agar (Anaerobe Systems) | ||
| 118701 | 0 |
| 29914 | Productionyes |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 6848 | BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58) | Medium recipe at MediaDive | Name: BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58) Composition: Glucose 10.0 g/l Casein peptone 10.0 g/l Bacto Soytone 5.0 g/l Meat extract 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l MnSO4 x H2O 0.05 g/l KH2PO4 0.04 g/l K2HPO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Tween 80 Resazurin Distilled water | ||
| 6848 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | Medium recipe at MediaDive | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base | ||
| 33163 | MEDIUM 6 - Columbia agar with 10 % horse blood | Distilled water make up to (1000.000 ml);Columbia agar (39.000 g);Horseblood (100.000 ml) | |||
| 26285 | Brucella blood agar (Anaerobe Systems) | ||||
| 118701 | CIP Medium 6 | Medium recipe at CIP |
| @ref | Ability | Type | PH | PH range | |
|---|---|---|---|---|---|
| 29914 | positive | growth | 5.5-11 | alkaliphile |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 26285 | 17256 ChEBI | 2-deoxyadenosine | + | assimilation | |
| 26285 | 16763 ChEBI | 2-oxobutanoate | + | assimilation | |
| 26285 | 28644 ChEBI | 2-oxopentanoate | + | assimilation | |
| 26285 | 73918 ChEBI | 3-O-methyl-D-glucose | + | assimilation | |
| 26285 | 17925 ChEBI | alpha-D-glucose | + | assimilation | |
| 26285 | 22599 ChEBI | arabinose | - | growth | |
| 26285 | 18305 ChEBI | arbutin | + | growth | |
| 68380 | 29016 ChEBI | arginine | - | hydrolysis | from API rID32A |
| 29914 | 17057 ChEBI | cellobiose | + | carbon source | |
| 26285 | 17057 ChEBI | cellobiose | + | assimilation | |
| 118701 | 17057 ChEBI | cellobiose | - | degradation | |
| 26285 | 62968 ChEBI | cellulose | - | hydrolysis | |
| 26285 | 62968 ChEBI | cellulose | + | growth | |
| 118701 | 17108 ChEBI | D-arabinose | - | degradation | |
| 26285 | 15824 ChEBI | D-fructose | + | assimilation | |
| 118701 | 15824 ChEBI | D-fructose | + | degradation | |
| 26285 | 12936 ChEBI | D-galactose | + | assimilation | |
| 26285 | 18024 ChEBI | D-galacturonic acid | + | assimilation | |
| 118701 | 17634 ChEBI | D-glucose | + | degradation | |
| 26285 | 16024 ChEBI | D-mannose | + | assimilation | |
| 68380 | 16024 ChEBI | D-mannose | - | fermentation | from API rID32A |
| 26285 | 16551 ChEBI | D-trehalose | + | assimilation | |
| 118701 | 65327 ChEBI | D-xylose | - | degradation | |
| 26285 | 23652 ChEBI | dextrin | + | assimilation | |
| 26285 | 4853 ChEBI | esculin | - | hydrolysis | |
| 118701 | 4853 ChEBI | esculin | - | hydrolysis | |
| 29914 | 28757 ChEBI | fructose | + | carbon source | |
| 26285 | 28757 ChEBI | fructose | + | growth | |
| 29914 | 28260 ChEBI | galactose | + | carbon source | |
| 29914 | 5291 ChEBI | gelatin | + | carbon source | |
| 26285 | 5291 ChEBI | gelatin | - | hydrolysis | |
| 29914 | 17234 ChEBI | glucose | + | carbon source | |
| 26285 | 17234 ChEBI | glucose | + | growth | |
| 26285 | 17596 ChEBI | inosine | + | assimilation | |
| 68380 | 29985 ChEBI | L-glutamate | - | degradation | from API rID32A |
| 26285 | 15589 ChEBI | L-malate | + | assimilation | |
| 26285 | 16414 ChEBI | L-valine | + | assimilation | |
| 26285 | 17716 ChEBI | lactose | - | growth | |
| 118701 | 17716 ChEBI | lactose | - | degradation | |
| 29914 | 17306 ChEBI | maltose | + | carbon source | |
| 26285 | 17306 ChEBI | maltose | - | growth | |
| 26285 | 17306 ChEBI | maltose | + | assimilation | |
| 118701 | 17306 ChEBI | maltose | - | degradation | |
| 26285 | 61993 ChEBI | maltotriose | + | assimilation | |
| 26285 | 29864 ChEBI | mannitol | - | growth | |
| 29914 | 37684 ChEBI | mannose | + | carbon source | |
| 26285 | 37684 ChEBI | mannose | + | growth | |
| 26285 | 6731 ChEBI | melezitose | - | growth | |
| 26285 | 28053 ChEBI | melibiose | - | growth | |
| 26285 | 17540 ChEBI | methyl beta-D-galactoside | + | assimilation | |
| 26285 | 320055 ChEBI | methyl beta-D-glucopyranoside | + | assimilation | |
| 26285 | 51850 ChEBI | methyl pyruvate | + | assimilation | |
| 26285 | 17268 ChEBI | myo-inositol | - | growth | |
| 26285 | 63153 ChEBI | N-acetyl-D-mannosamine | + | assimilation | |
| 26285 | 506227 ChEBI | N-acetylglucosamine | + | assimilation | |
| 26285 | 17632 ChEBI | nitrate | - | reduction | |
| 68380 | 17632 ChEBI | nitrate | - | reduction | from API rID32A |
| 118701 | 17632 ChEBI | nitrate | - | reduction | |
| 118701 | 17632 ChEBI | nitrate | + | respiration | |
| 118701 | 16301 ChEBI | nitrite | - | reduction | |
| 26285 | 18394 ChEBI | palatinose | + | assimilation | |
| 26285 | peptone | - | growth | ||
| 26285 | 15361 ChEBI | pyruvate | + | assimilation | |
| 26285 | 16634 ChEBI | raffinose | - | growth | |
| 68380 | 16634 ChEBI | raffinose | - | fermentation | from API rID32A |
| 26285 | 26546 ChEBI | rhamnose | - | growth | |
| 26285 | 33942 ChEBI | ribose | - | growth | |
| 26285 | 17814 ChEBI | salicin | - | growth | |
| 118701 | 17814 ChEBI | salicin | - | degradation | |
| 26285 | 17822 ChEBI | serine | + | assimilation | |
| 26285 | 30911 ChEBI | sorbitol | - | growth | |
| 26285 | 28017 ChEBI | starch | - | growth | |
| 118701 | 17992 ChEBI | sucrose | + | degradation | |
| 26285 | 17748 ChEBI | thymidine | + | assimilation | |
| 29914 | 27082 ChEBI | trehalose | + | carbon source | |
| 26285 | 32528 ChEBI | turanose | + | assimilation | |
| 26285 | 16199 ChEBI | urea | - | hydrolysis | |
| 68380 | 16199 ChEBI | urea | - | hydrolysis | from API rID32A |
| 26285 | 16704 ChEBI | uridine | + | assimilation | |
| 26285 | 18222 ChEBI | xylose | - | growth |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 26285 | 6-phospho-beta-galactosidase | - | 3.2.1.85 | |
| 26285 | acid phosphatase | + | 3.1.3.2 | |
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 68380 | alanine arylamidase | - | 3.4.11.2 | from API rID32A |
| 26285 | alkaline phosphatase | - | 3.1.3.1 | |
| 68382 | alkaline phosphatase | - | 3.1.3.1 | from API zym |
| 26285 | alpha-arabinosidase | - | 3.2.1.55 | |
| 68380 | alpha-arabinosidase | - | 3.2.1.55 | from API rID32A |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 26285 | alpha-fucosidase | - | 3.2.1.51 | |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68380 | alpha-fucosidase | - | 3.2.1.51 | from API rID32A |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68380 | alpha-galactosidase | - | 3.2.1.22 | from API rID32A |
| 26285 | alpha-glucosidase | - | 3.2.1.20 | |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68380 | alpha-glucosidase | - | 3.2.1.20 | from API rID32A |
| 26285 | alpha-mannosidase | - | 3.2.1.24 | |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 26285 | arginine arylamidase | - | ||
| 26285 | arginine dihydrolase | - | 3.5.3.6 | |
| 68380 | arginine dihydrolase | - | 3.5.3.6 | from API rID32A |
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 118701 | beta-galactosidase | - | 3.2.1.23 | |
| 68380 | beta-galactosidase | - | 3.2.1.23 | from API rID32A |
| 68380 | beta-Galactosidase 6-phosphate | - | from API rID32A | |
| 26285 | beta-glucosidase | - | 3.2.1.21 | |
| 68382 | beta-glucosidase | + | 3.2.1.21 | from API zym |
| 26285 | beta-glucuronidase | - | 3.2.1.31 | |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 68380 | beta-glucuronidase | - | 3.2.1.31 | from API rID32A |
| 26285 | catalase | - | 1.11.1.6 | |
| 118701 | catalase | - | 1.11.1.6 | |
| 26285 | chymotrypsin | - | 3.4.4.5 | |
| 26285 | cystine arylamidase | - | 3.4.11.3 | |
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 26285 | esterase (C 4) | - | ||
| 68382 | esterase (C 4) | + | from API zym | |
| 26285 | esterase Lipase (C 8) | - | ||
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 118701 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 118701 | gelatinase | - | ||
| 26285 | glutamate decarboxylase | - | 4.1.1.15 | |
| 68380 | glutamate decarboxylase | - | 4.1.1.15 | from API rID32A |
| 26285 | glutamyl-glutamate arylamidase | - | ||
| 68380 | glutamyl-glutamate arylamidase | - | from API rID32A | |
| 26285 | glycin arylamidase | - | ||
| 68380 | glycin arylamidase | - | from API rID32A | |
| 26285 | histidine arylamidase | - | ||
| 68380 | histidine arylamidase | - | from API rID32A | |
| 68380 | L-arginine arylamidase | - | from API rID32A | |
| 26285 | leucine arylamidase | - | 3.4.11.1 | |
| 68382 | leucine arylamidase | - | 3.4.11.1 | from API zym |
| 68380 | leucine arylamidase | - | 3.4.11.1 | from API rID32A |
| 26285 | leucyl glycin arylamidase | - | 3.4.11.1 | |
| 68380 | leucyl glycin arylamidase | - | 3.4.11.1 | from API rID32A |
| 26285 | lipase (C 14) | - | ||
| 68382 | lipase (C 14) | - | from API zym | |
| 26285 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68380 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API rID32A |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 118701 | oxidase | - | ||
| 26285 | phenylalanine arylamidase | - | ||
| 68380 | phenylalanine arylamidase | - | from API rID32A | |
| 26285 | phosphoamidase | - | 3.9.1.1 | |
| 26285 | proline-arylamidase | - | 3.4.11.5 | |
| 68380 | proline-arylamidase | - | 3.4.11.5 | from API rID32A |
| 26285 | pyroglutamic acid arylamidase | - | ||
| 68380 | pyrrolidonyl arylamidase | - | 3.4.19.3 | from API rID32A |
| 26285 | serine arylamidase | - | ||
| 68380 | serine arylamidase | - | from API rID32A | |
| 26285 | trypsin | - | 3.4.21.4 | |
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 26285 | tyrosine arylamidase | - | ||
| 68380 | tyrosine arylamidase | - | from API rID32A | |
| 118701 | urease | - | 3.5.1.5 | |
| 68380 | urease | - | 3.5.1.5 | from API rID32A |
| 26285 | valine arylamidase | - | ||
| 68382 | valine arylamidase | - | from API zym |
| @ref | pathway | enzyme coverage | annotated reactions | external links | |
|---|---|---|---|---|---|
| 66794 | formaldehyde oxidation | 100 | 3 of 3 | ||
| 66794 | cis-vaccenate biosynthesis | 100 | 2 of 2 | ||
| 66794 | adipate degradation | 100 | 2 of 2 | ||
| 66794 | methylglyoxal degradation | 100 | 5 of 5 | ||
| 66794 | coenzyme A metabolism | 100 | 4 of 4 | ||
| 66794 | L-lactaldehyde degradation | 100 | 3 of 3 | ||
| 66794 | CDP-diacylglycerol biosynthesis | 100 | 2 of 2 | ||
| 66794 | starch degradation | 100 | 10 of 10 | ||
| 66794 | UDP-GlcNAc biosynthesis | 100 | 3 of 3 | ||
| 66794 | folate polyglutamylation | 100 | 1 of 1 | ||
| 66794 | suberin monomers biosynthesis | 100 | 2 of 2 | ||
| 66794 | anapleurotic synthesis of oxalacetate | 100 | 1 of 1 | ||
| 66794 | reductive acetyl coenzyme A pathway | 100 | 7 of 7 | ||
| 66794 | palmitate biosynthesis | 90.91 | 20 of 22 | ||
| 66794 | threonine metabolism | 90 | 9 of 10 | ||
| 66794 | chorismate metabolism | 88.89 | 8 of 9 | ||
| 66794 | serine metabolism | 88.89 | 8 of 9 | ||
| 66794 | isoleucine metabolism | 87.5 | 7 of 8 | ||
| 66794 | ketogluconate metabolism | 87.5 | 7 of 8 | ||
| 66794 | vitamin B1 metabolism | 84.62 | 11 of 13 | ||
| 66794 | glycine betaine biosynthesis | 80 | 4 of 5 | ||
| 66794 | Entner Doudoroff pathway | 80 | 8 of 10 | ||
| 66794 | propionate fermentation | 80 | 8 of 10 | ||
| 66794 | peptidoglycan biosynthesis | 80 | 12 of 15 | ||
| 66794 | heme metabolism | 78.57 | 11 of 14 | ||
| 66794 | photosynthesis | 78.57 | 11 of 14 | ||
| 66794 | glutamate and glutamine metabolism | 78.57 | 22 of 28 | ||
| 66794 | aspartate and asparagine metabolism | 77.78 | 7 of 9 | ||
| 66794 | NAD metabolism | 77.78 | 14 of 18 | ||
| 66794 | CO2 fixation in Crenarchaeota | 77.78 | 7 of 9 | ||
| 66794 | purine metabolism | 77.66 | 73 of 94 | ||
| 66794 | phenylalanine metabolism | 76.92 | 10 of 13 | ||
| 66794 | vitamin B12 metabolism | 76.47 | 26 of 34 | ||
| 66794 | alanine metabolism | 75.86 | 22 of 29 | ||
| 66794 | glycogen biosynthesis | 75 | 3 of 4 | ||
| 66794 | acetate fermentation | 75 | 3 of 4 | ||
| 66794 | CMP-KDO biosynthesis | 75 | 3 of 4 | ||
| 66794 | gluconeogenesis | 75 | 6 of 8 | ||
| 66794 | C4 and CAM-carbon fixation | 75 | 6 of 8 | ||
| 66794 | ppGpp biosynthesis | 75 | 3 of 4 | ||
| 66794 | pyrimidine metabolism | 73.33 | 33 of 45 | ||
| 66794 | methionine metabolism | 73.08 | 19 of 26 | ||
| 66794 | cardiolipin biosynthesis | 71.43 | 5 of 7 | ||
| 66794 | degradation of pentoses | 67.86 | 19 of 28 | ||
| 66794 | valine metabolism | 66.67 | 6 of 9 | ||
| 66794 | degradation of hexoses | 66.67 | 12 of 18 | ||
| 66794 | octane oxidation | 66.67 | 2 of 3 | ||
| 66794 | cyanate degradation | 66.67 | 2 of 3 | ||
| 66794 | acetoin degradation | 66.67 | 2 of 3 | ||
| 66794 | molybdenum cofactor biosynthesis | 66.67 | 6 of 9 | ||
| 66794 | selenocysteine biosynthesis | 66.67 | 4 of 6 | ||
| 66794 | oxidative phosphorylation | 64.84 | 59 of 91 | ||
| 66794 | glycolysis | 64.71 | 11 of 17 | ||
| 66794 | citric acid cycle | 64.29 | 9 of 14 | ||
| 66794 | dTDPLrhamnose biosynthesis | 62.5 | 5 of 8 | ||
| 66794 | degradation of sugar alcohols | 62.5 | 10 of 16 | ||
| 66794 | glycogen metabolism | 60 | 3 of 5 | ||
| 66794 | hydrogen production | 60 | 3 of 5 | ||
| 66794 | metabolism of amino sugars and derivatives | 60 | 3 of 5 | ||
| 66794 | myo-inositol biosynthesis | 60 | 6 of 10 | ||
| 66794 | degradation of aromatic, nitrogen containing compounds | 58.33 | 7 of 12 | ||
| 66794 | tetrahydrofolate metabolism | 57.14 | 8 of 14 | ||
| 66794 | propanol degradation | 57.14 | 4 of 7 | ||
| 66794 | d-mannose degradation | 55.56 | 5 of 9 | ||
| 66794 | cysteine metabolism | 55.56 | 10 of 18 | ||
| 66794 | histidine metabolism | 55.17 | 16 of 29 | ||
| 66794 | proline metabolism | 54.55 | 6 of 11 | ||
| 66794 | vitamin B6 metabolism | 54.55 | 6 of 11 | ||
| 66794 | sulfate reduction | 53.85 | 7 of 13 | ||
| 66794 | leucine metabolism | 53.85 | 7 of 13 | ||
| 66794 | flavin biosynthesis | 53.33 | 8 of 15 | ||
| 66794 | tryptophan metabolism | 52.63 | 20 of 38 | ||
| 66794 | degradation of sugar acids | 52 | 13 of 25 | ||
| 66794 | butanoate fermentation | 50 | 2 of 4 | ||
| 66794 | aminopropanol phosphate biosynthesis | 50 | 1 of 2 | ||
| 66794 | 6-hydroxymethyl-dihydropterin diphosphate biosynthesis | 50 | 4 of 8 | ||
| 66794 | lactate fermentation | 50 | 2 of 4 | ||
| 66794 | ribulose monophosphate pathway | 50 | 1 of 2 | ||
| 66794 | glycine metabolism | 50 | 5 of 10 | ||
| 66794 | glycolate and glyoxylate degradation | 50 | 3 of 6 | ||
| 66794 | tyrosine metabolism | 50 | 7 of 14 | ||
| 66794 | lysine metabolism | 50 | 21 of 42 | ||
| 66794 | arginine metabolism | 50 | 12 of 24 | ||
| 66794 | sulfopterin metabolism | 50 | 2 of 4 | ||
| 66794 | non-pathway related | 50 | 19 of 38 | ||
| 66794 | ethanol fermentation | 50 | 1 of 2 | ||
| 66794 | biotin biosynthesis | 50 | 2 of 4 | ||
| 66794 | lipid metabolism | 48.39 | 15 of 31 | ||
| 66794 | urea cycle | 46.15 | 6 of 13 | ||
| 66794 | pentose phosphate pathway | 45.45 | 5 of 11 | ||
| 66794 | ascorbate metabolism | 45.45 | 10 of 22 | ||
| 66794 | nitrate assimilation | 44.44 | 4 of 9 | ||
| 66794 | ubiquinone biosynthesis | 42.86 | 3 of 7 | ||
| 66794 | isoprenoid biosynthesis | 42.31 | 11 of 26 | ||
| 66794 | factor 420 biosynthesis | 40 | 2 of 5 | ||
| 66794 | arachidonate biosynthesis | 40 | 2 of 5 | ||
| 66794 | coenzyme M biosynthesis | 40 | 4 of 10 | ||
| 66794 | metabolism of disaccharids | 36.36 | 4 of 11 | ||
| 66794 | d-xylose degradation | 36.36 | 4 of 11 | ||
| 66794 | IAA biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | acetyl CoA biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | enterobactin biosynthesis | 33.33 | 1 of 3 | ||
| 66794 | pantothenate biosynthesis | 33.33 | 2 of 6 | ||
| 66794 | sphingosine metabolism | 33.33 | 2 of 6 | ||
| 66794 | lipid A biosynthesis | 33.33 | 3 of 9 | ||
| 66794 | glutathione metabolism | 28.57 | 4 of 14 | ||
| 66794 | benzoyl-CoA degradation | 28.57 | 2 of 7 | ||
| 66794 | dolichyl-diphosphooligosaccharide biosynthesis | 27.27 | 3 of 11 | ||
| 66794 | polyamine pathway | 26.09 | 6 of 23 | ||
| 66794 | carnitine metabolism | 25 | 2 of 8 | ||
| 66794 | cyclohexanol degradation | 25 | 1 of 4 | ||
| 66794 | toluene degradation | 25 | 1 of 4 | ||
| 66794 | allantoin degradation | 22.22 | 2 of 9 |
| @ref | URE | ADH (Arg) | alpha GAL | beta GAL | beta-Galactosidase 6-phosphatebeta GP | alpha GLU | beta GLU | alpha ARA | beta GUR | beta-N-Acetyl-beta-glucosaminidasebeta NAG | MNE | RAF | GDC | alpha FUC | Reduction of nitrateNIT | IND | PAL | L-arginine arylamidaseArgA | ProA | LGA | Phenylalanine arylamidasePheA | Leucine arylamidaseLeuA | PyrA | Tyrosine arylamidaseTyrA | Alanine arylamidaseAlaA | Glycin arylamidaseGlyA | Histidine arylamidaseHisA | Glutamyl-glutamate arylamidaseGGA | Serine arylamidaseSerA | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6848 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - | - | |
| 6848 | - | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - | + | - | - | - | - | - | - | - | - | - | - | - | - |
| Cat1 | Cat2 | Cat3 | |
|---|---|---|---|
| #Host | #Human | #Child | |
| #Host Body Product | #Gastrointestinal tract | #Feces (Stool) |
| @ref | Sample type | Host species | Geographic location | Country | Country ISO 3 Code | Continent | |
|---|---|---|---|---|---|---|---|
| 6848 | human feces, autistic child | Homo sapiens | Chicago | USA | USA | North America | |
| 26285 | faecal material of a 71-month old autistic child from the Rushs Childrens Hospital | Homo sapiens | Chicago | USA | USA | North America | |
| 56619 | Human feces from autistic child | Homo sapiens | California | USA | USA | North America | |
| 67770 | Human feces | Homo sapiens | |||||
| 118701 | Human, Feces | Homo sapiens | United States of America | USA | North America |
Global distribution of 16S sequence AJ315980 (>99% sequence identity) for Anaerotruncus colihominis subclade from Microbeatlas ![]()
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM2514613v1 assembly for Anaerotruncus colihominis DSM 17241 | complete | 169435 | 97.94 | ||||
| 67770 | ASM15456v1 assembly for Anaerotruncus colihominis DSM 17241 | scaffold | 445972 | 68.35 |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125439 | oxygen_tolerance | BacteriaNetⓘ | obligate anaerobe | 95.49 | no |
| 125439 | motility | BacteriaNetⓘ | no | 61.17 | no |
| 125439 | gram_stain | BacteriaNetⓘ | positive | 41.07 | no |
| 125439 | spore_formation | BacteriaNetⓘ | no | 75.46 | no |
| @ref | Trait | Model | Prediction | Confidence in % | In training data |
|---|---|---|---|---|---|
| 125438 | gram-positive | gram-positiveⓘ | yes | 66.56 | yes |
| 125438 | anaerobic | anaerobicⓘ | yes | 91.72 | yes |
| 125438 | aerobic | aerobicⓘ | no | 94.60 | yes |
| 125438 | spore-forming | spore-formingⓘ | no | 51.13 | no |
| 125438 | thermophilic | thermophileⓘ | no | 86.23 | yes |
| 125438 | flagellated | motile2+ⓘ | yes | 58.85 | no |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Coarse-grained model of serial dilution dynamics in synthetic human gut microbiome. | Mahajan T, Maslov S. | PLoS Comput Biol | 10.1371/journal.pcbi.1013222 | 2025 | ||
| Metabolism | Potentially Bio-Accessible Metabolites from an Extract of Cornus mas Fruit after Gastrointestinal Digestion In Vitro and Gut Microbiota Ex Vivo Treatment. | Oledzka A, Cichocka K, Wolinski K, Melzig MF, Czerwinska ME. | Nutrients | 10.3390/nu14112287 | 2022 | |
| A Robust Metatranscriptomic Technology for Population-Scale Studies of Diet, Gut Microbiome, and Human Health. | Hatch A, Horne J, Toma R, Twibell BL, Somerville KM, Pelle B, Canfield KP, Genkin M, Banavar G, Perlina A, Messier H, Klitgord N, Vuyisich M. | Int J Genomics | 10.1155/2019/1718741 | 2019 | ||
| Culturing of a complex gut microbial community in mucin-hydrogel carriers reveals strain- and gene-associated spatial organization. | Jin X, Yu FB, Yan J, Weakley AM, Dubinkina V, Meng X, Pollard KS. | Nat Commun | 10.1038/s41467-023-39121-0 | 2023 | ||
| The SHOCT domain: a widespread domain under-represented in model organisms. | Eberhardt RY, Bartholdson SJ, Punta M, Bateman A. | PLoS One | 10.1371/journal.pone.0057848 | 2013 | ||
| Metabolism | Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation. | Wlodarska M, Luo C, Kolde R, d'Hennezel E, Annand JW, Heim CE, Krastel P, Schmitt EK, Omar AS, Creasey EA, Garner AL, Mohammadi S, O'Connell DJ, Abubucker S, Arthur TD, Franzosa EA, Huttenhower C, Murphy LO, Haiser HJ, Vlamakis H, Porter JA, Xavier RJ. | Cell Host Microbe | 10.1016/j.chom.2017.06.007 | 2017 | |
| Genetics | The Primary Research on the Gut Microbes in KKAy Mice. | Li Y, Han L, Xu M, Guo J, Feng M, Wang X. | Indian J Microbiol | 10.1007/s12088-013-0410-3 | 2014 | |
| Metabolism | Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome. | Wang M, Osborn LJ, Jain S, Meng X, Weakley A, Yan J, Massey WJ, Varadharajan V, Horak A, Banerjee R, Allende DS, Chan ER, Hajjar AM, Wang Z, Dimas A, Zhao A, Nagashima K, Cheng AG, Higginbottom S, Hazen SL, Brown JM, Fischbach MA. | Cell | 10.1016/j.cell.2023.05.037 | 2023 | |
| Functional Comparison of Bacteria from the Human Gut and Closely Related Non-Gut Bacteria Reveals the Importance of Conjugation and a Paucity of Motility and Chemotaxis Functions in the Gut Environment. | Dobrijevic D, Abraham AL, Jamet A, Maguin E, van de Guchte M. | PLoS One | 10.1371/journal.pone.0159030 | 2016 | ||
| Metabolism | Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53. | Nguyen C, Nguyen VD. | Biomed Res Int | 10.1155/2016/8490482 | 2016 | |
| The Metadata Coverage Index (MCI): A standardized metric for quantifying database metadata richness. | Liolios K, Schriml L, Hirschman L, Pagani I, Nosrat B, Sterk P, White O, Rocca-Serra P, Sansone SA, Taylor C, Kyrpides NC, Field D. | Stand Genomic Sci | 10.4056/sigs.2675953 | 2012 | ||
| Phylogeny | A primary assessment of the endophytic bacterial community in a xerophilous moss (Grimmia montana) using molecular method and cultivated isolates. | Liu XL, Liu SL, Liu M, Kong BH, Liu L, Li YH. | Braz J Microbiol | 10.1590/s1517-83822014000100022 | 2014 | |
| Analysis of the mobilization functions of the vancomycin resistance transposon Tn1549, a member of a new family of conjugative elements. | Tsvetkova K, Marvaud JC, Lambert T. | J Bacteriol | 10.1128/jb.00680-09 | 2010 | ||
| Genetics | Single-cell sequencing provides clues about the host interactions of segmented filamentous bacteria (SFB). | Pamp SJ, Harrington ED, Quake SR, Relman DA, Blainey PC. | Genome Res | 10.1101/gr.131482.111 | 2012 | |
| Design, construction, and in vivo augmentation of a complex gut microbiome. | Cheng AG, Ho PY, Aranda-Diaz A, Jain S, Yu FB, Meng X, Wang M, Iakiviak M, Nagashima K, Zhao A, Murugkar P, Patil A, Atabakhsh K, Weakley A, Yan J, Brumbaugh AR, Higginbottom S, Dimas A, Shiver AL, Deutschbauer A, Neff N, Sonnenburg JL, Huang KC, Fischbach MA. | Cell | 10.1016/j.cell.2022.08.003 | 2022 | ||
| Metabolism | Alternative spermidine biosynthetic route is critical for growth of Campylobacter jejuni and is the dominant polyamine pathway in human gut microbiota. | Hanfrey CC, Pearson BM, Hazeldine S, Lee J, Gaskin DJ, Woster PM, Phillips MA, Michael AJ. | J Biol Chem | 10.1074/jbc.m111.307835 | 2011 | |
| Characterization of Lactococcus lactis phage 949 and comparison with other lactococcal phages. | Samson JE, Moineau S. | Appl Environ Microbiol | 10.1128/aem.00796-10 | 2010 | ||
| Pathogenicity | Vesiculation from Pseudomonas aeruginosa under SOS. | Maredia R, Devineni N, Lentz P, Dallo SF, Yu J, Guentzel N, Chambers J, Arulanandam B, Haskins WE, Weitao T. | ScientificWorldJournal | 10.1100/2012/402919 | 2012 | |
| The RepA_N replicons of Gram-positive bacteria: a family of broadly distributed but narrow host range plasmids. | Weaver KE, Kwong SM, Firth N, Francia MV. | Plasmid | 10.1016/j.plasmid.2008.11.004 | 2009 | ||
| Metabolism | ABC transporters involved in export of cell surface glycoconjugates. | Cuthbertson L, Kos V, Whitfield C. | Microbiol Mol Biol Rev | 10.1128/mmbr.00009-10 | 2010 | |
| Multi-omic analyses of the development of obesity-related depression linked to the gut microbe Anaerotruncus colihominis and its metabolite glutamate. | Chang Z, Zhu Y, Wang P, Du L, Wu M, Wang X, Kong C, Huang D, Xie R, Ji G, Wang C, Cheng L, Yan X, Wei Q, Qin H. | Sci Bull (Beijing) | 10.1016/j.scib.2025.04.010 | 2025 | ||
| Phylogeny | Full-length 16S rRNA sequencing revealed an altered microbiome diversity and composition of the jejunum and cecum in chicken infected with Eimeria necatrix. | Xue N, Feng Q, Zhu Y, Cheng C, Wang F, Liu D, Su S, Xu J, Hu J, Tao J. | Vet Parasitol | 10.1016/j.vetpar.2025.110458 | 2025 | |
| Dysregulation of gut microbiota stimulates NETs-driven HCC intrahepatic metastasis: therapeutic implications of healthy faecal microbiota transplantation. | Deng Z, Mei S, Ouyang Z, Wang R, Wang L, Zou B, Dai J, Mao K, Li Q, Guo Q, Yi C, Meng F, Xie M, Zhang X, Wang R, Deng T, Wang Z, Li X, Wang Q, Liu B, Tian X. | Gut Microbes | 10.1080/19490976.2025.2476561 | 2025 | ||
| Genetics | Metagenomics Analysis Reveals Unique Gut Microbiota Signature of Slow-Transit Constipation. | Han K, Kuo B, Khalili H, Staller K. | Clin Transl Gastroenterol | 10.14309/ctg.0000000000000766 | 2024 | |
| Plant Heteropolysaccharides as Potential Anti-Diabetic Agents: A Review. | He D, Cui C. | Curr Issues Mol Biol | 10.3390/cimb47070533 | 2025 | ||
| Genetics | Cognitive Function Associated with Gut Microbial Abundance in Sucrose and S-Adenosyl-L-Methionine (SAMe) Metabolic Pathways. | Jeong S, Huang LK, Tsai MJ, Liao YT, Lin YS, Hu CJ, Hsu YH. | J Alzheimers Dis | 10.3233/jad-215090 | 2022 | |
| The effect of culturing temperature on the growth of the most dominant bacterial species of human gut microbiota and harmful bacterial species. | Shimokawa H, Sakakibara H, Ami Y, Hirano R, Kurihara S. | Biosci Microbiota Food Health | 10.12938/bmfh.2024-087 | 2025 | ||
| Akkermansia muciniphila is associated with normal muscle mass and Eggerthella is related with sarcopenia in cirrhosis. | Efremova I, Alieva A, Maslennikov R, Poluektova E, Zharkova M, Kudryavtseva A, Krasnov G, Zharikov Y, Nerestyuk Y, Karchevskaya A, Ivashkin V. | Front Nutr | 10.3389/fnut.2024.1438897 | 2024 | ||
| Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins trigger MS-like disease in germfree transgenic mice-An unbiased functional study. | Yoon H, Gerdes LA, Beigel F, Sun Y, Kovilein J, Wang J, Kuhlmann T, Flierl-Hecht A, Haller D, Hohlfeld R, Baranzini SE, Wekerle H, Peters A. | Proc Natl Acad Sci U S A | 10.1073/pnas.2419689122 | 2025 | ||
| Pathogenicity | Immuno-Microbial Signature of Vaccine-Induced Immunity against SARS-CoV-2. | Umeda L, Torres A, Kunihiro BP, Rubas NC, Wells RK, Phankitnirundorn K, Peres R, Juarez R, Maunakea AK. | Vaccines (Basel) | 10.3390/vaccines12060637 | 2024 | |
| Temporal network analysis of gut microbiota unveils aging trajectories associated with colon cancer. | Chen Z, Zhang Z, Nie BN, Huang W, Zhu Y, Zhang L, Xu M, Wang M, Yuan C, Liu N, Wang X, Tian J, Ba Q, Wang Z. | mSystems | 10.1128/msystems.01188-24 | 2025 | ||
| Machine learning prediction of obesity-associated gut microbiota: identifying Bifidobacterium pseudocatenulatum as a potential therapeutic target. | Wu H, Li Y, Jiang Y, Li X, Wang S, Zhao C, Yang X, Chang B, Yang J, Qiao J. | Front Microbiol | 10.3389/fmicb.2024.1488656 | 2024 | ||
| Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Modulating Protein-Bound Uremic Toxins and Gut Microbiota in Predialysis CKD Patients: Matched Case-Control Study. | Hsu CK, Chang LC, Chen YT, Chen CY, Hsu HR, Bai S, Lee CC, Lee CC, Jangir H, Sun CY, Su SC, Wu IW. | Kidney360 | 10.34067/kid.0000000792 | 2025 | ||
| Mining the microbiota to identify gut commensals modulating neuroinflammation in a mouse model of multiple sclerosis. | Bianchimano P, Britton GJ, Wallach DS, Smith EM, Cox LM, Liu S, Iwanowski K, Weiner HL, Faith JJ, Clemente JC, Tankou SK. | Microbiome | 10.1186/s40168-022-01364-2 | 2022 | ||
| From Compensation to Collapse: UVB-Driven Disruption of Host-Microbiota Homeostasis Exacerbates Amphibian Ecological Risk. | Yuan Z, Fei J, Li S, Wu Y, Liu P. | Animals (Basel) | 10.3390/ani15223236 | 2025 | ||
| Phenotype | Stratification of Gut Microbiota Profiling Based on Autism Neuropsychological Assessments. | Marangelo C, Vernocchi P, Del Chierico F, Scanu M, Marsiglia R, Petrolo E, Fuca E, Guerrera S, Valeri G, Vicari S, Putignani L. | Microorganisms | 10.3390/microorganisms12102041 | 2024 | |
| Metabolomics and metagenomics in mice reveal the role of the gut microbiota in tryptophan metabolism. | Leve M, Manghi P, Bredon M, Lefevre A, Manara S, Armanini F, Emond P, Planchais J, Rolhion N, Segata N, Sokol H. | iScience | 10.1016/j.isci.2025.113751 | 2025 | ||
| Genetics | Diet-Gut Microbiota Relations: Critical Appraisal of Evidence From Studies Using Metagenomics. | Lotankar M, Houttu N, Mokkala K, Laitinen K. | Nutr Rev | 10.1093/nutrit/nuae192 | 2025 | |
| Characterization and Evaluation of Lactobacillus plantarum LC5.2 Isolated from Thai Native Pigs for its Probiotic Potential in Gut Microbiota Modulation and Immune Enhancement. | Khongkool K, Taweechotipatr M, Payungporn S, Sawaswong V, Lertworapreecha M. | J Microbiol Biotechnol | 10.4014/jmb.2503.03028 | 2025 | ||
| Advanced Age Worsens Respiratory Function and Pulmonary Inflammation After Burn Injury and This Correlates With Changes in the Fecal Microbiome in Mice. | McMahan RH, Boe D, Giesy LE, Najarro KM, Khair S, Walrath T, Frank DN, Kovacs EJ. | J Burn Care Res | 10.1093/jbcr/irae101 | 2025 | ||
| Metabolism | Combined metagenomic and metabolomic analyses reveal gut microbiota dysbiosis and metabolic dysfunction in pediatric neurodevelopmental disorders. | Wang Q, Luo Y, Mao C, Xiang X, Chen J. | Front Immunol | 10.3389/fimmu.2025.1645137 | 2025 | |
| Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker Potential. | Nemati MH, Yazdanpanah E, Kazemi R, Orooji N, Dadfar S, Oksenych V, Haghmorad D. | Biology (Basel) | 10.3390/biology14040435 | 2025 | ||
| Gut Microbial Changes Associated With Obesity in Youth With Type 1 Diabetes. | Ismail HM, Perera D, Mandal R, DiMeglio LA, Evans-Molina C, Hannon T, Petrosino J, Javornik Cregeen S, Schmidt NW. | J Clin Endocrinol Metab | 10.1210/clinem/dgae529 | 2025 | ||
| A comparative pharmacological study of three Chinese traditional medicines found Blautia to be the key functional bacterium of Coptis chinensis Franch. and Phellodendri chinensis Cortex against colitis. | Zhan J, Cheng J, Yang Y, Xu X, Lu Z, Li L, Li H, Yang Q, Hu Y, Song Y, Fan Q, Yang E, Liang Q, Sun S, Qiu F, Cao Y, Wu C. | Front Pharmacol | 10.3389/fphar.2025.1587119 | 2025 | ||
| Functional recovery outcomes following acute stroke is associated with abundance of gut microbiota related to inflammation, butyrate and secondary bile acid. | Hammond TC, Powell E, Green SJ, Chlipala G, Frank J, Yackzan AT, Yanckello LM, Chang YH, Xing X, Heil S, Springer JE, Pennypacker K, Stromberg A, Sawaki L, Lin AL. | Front Rehabil Sci | 10.3389/fresc.2022.1017180 | 2022 | ||
| High-fat diet and estrogen modulate the gut microbiota in a sex-dependent manner in mice. | Hases L, Stepanauskaite L, Birgersson M, Brusselaers N, Schuppe-Koistinen I, Archer A, Engstrand L, Williams C. | Commun Biol | 10.1038/s42003-022-04406-5 | 2023 | ||
| Gut microbiota dysbiosis and metabolic perturbations of bile/glyceric acids in major depressive disorder with IBS comorbidity. | Du J-Y, Zhang Z-J, Tan L, Yang J-Y, Yang R-N, Chen Y-L, Tan G-F, Li J, Li W-J, Yang L, Cai J, Shen D-L, Zhu H-R, Fan Z-X, Yuan M-L, Zhang W. | mBio | 10.1128/mbio.02447-25 | 2025 | ||
| Long-term Metformin Alters Gut Microbiota and Serum Metabolome in Coronary Artery Disease Patients After Percutaneous Coronary Intervention to Improve 5-year Prognoses: A Multi-omics Analysis | Zhou R, Wu Q, Qian H, Wang L, Liu G, Zhang B, Wu W, Zhang S. | Rev Cardiovasc Med | 2025 | |||
| Genetics | Gut microbiome signatures in iNPH: Insights from a shotgun metagenomics study. | Park R, Chevalier C, Kieser S, Marizzoni M, Paquis A, Armand S, Scheffler M, Allali G, Assal F, Momjian S, Frisoni GB. | PLoS One | 10.1371/journal.pone.0330251 | 2025 | |
| Gut microbiome composition and metabolic activity in women with diverticulitis. | Ma W, Wang Y, Nguyen LH, Mehta RS, Ha J, Bhosle A, Mclver LJ, Song M, Clish CB, Strate LL, Huttenhower C, Chan AT. | Nat Commun | 10.1038/s41467-024-47859-4 | 2024 | ||
| Impact of broad-spectrum antibiotics on the gut-microbiota-spleen-brain axis. | Wan X, Eguchi A, Sakamoto A, Fujita Y, Yang Y, Qu Y, Hatano M, Mori C, Hashimoto K. | Brain Behav Immun Health | 10.1016/j.bbih.2022.100573 | 2023 | ||
| Characterization of the gut microbiota and fecal and blood metabolomes under various factors in urban children from Northwest China. | Yang Y, Chen J, Gao H, Cui M, Zhu M, Xiang X, Wang Q. | Front Cell Infect Microbiol | 10.3389/fcimb.2024.1374544 | 2024 | ||
| Metabolism | Insights from metagenomics into gut microbiome associated with acute coronary syndrome therapy. | Guan Y, Zhao S, Li J, Zhang W, Guo Z, Luo Y, Jiang X, Li J, Liu J, Chen X, Zhao Z, Zhang Z. | Front Microbiol | 10.3389/fmicb.2024.1369478 | 2024 | |
| Gut Microbial Signatures of Distinct Trimethylamine N-Oxide Response to Raspberry Consumption. | Franck M, de Toro-Martin J, V Varin T, Garneau V, Pilon G, Roy D, Couture P, Couillard C, Marette A, Vohl MC. | Nutrients | 10.3390/nu14081656 | 2022 | ||
| Sodium Butyrate Inhibits Necroptosis by Regulating MLKL via E2F1 in Intestinal Epithelial Cells of Liver Cirrhosis. | Zhou Y, Ding Y, Li Y, Sheng Q, Han C, Fan Y, Wang Z, Lu B, Dou X, Zhang C. | J Clin Transl Hepatol | 10.14218/jcth.2024.00221 | 2025 | ||
| Environmental Impact on Differential Composition of Gut Microbiota in Indoor Chickens in Commercial Production and Outdoor, Backyard Chickens. | Seidlerova Z, Kubasova T, Faldynova M, Crhanova M, Karasova D, Babak V, Rychlik I. | Microorganisms | 10.3390/microorganisms8050767 | 2020 | ||
| Pathogenicity | Blood-borne immune cells carry low biomass DNA remnants of microbes in patients with colorectal cancer or inflammatory bowel disease. | Morsy Y, Walberg A, Wawrzyniak P, Hubeli B, Truscello L, Mamie C, Niechcial A, Gueguen E, Manzini R, Gottier C, Lang S, Scharl S, Blumel S, Biedermann L, Rogler G, Turina M, Ramser M, Petrowsky H, Arnold IC, Zeissig S, Zamboni N, Egli A, Niess JH, Hruz P, Knuth A, Fritsch R, Manz MG, Wawrzyniak M, Scharl M. | Gut Microbes | 10.1080/19490976.2025.2530157 | 2025 | |
| High-resolution analysis of the treated coeliac disease microbiome reveals strain-level variation. | Slager J, Simpson HL, Gacesa R, Chen L, Tan IL, Gelderloos J, Maatman A, Wijmenga C, Zhernakova A, Fu J, Weersma RK, Gonera G, Jonkers IH, Withoff S. | Gut Microbes | 10.1080/19490976.2025.2489071 | 2025 | ||
| Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous mycobacterial pulmonary disease. | Choi JY, Shim B, Park Y, Kang YA. | Korean J Intern Med | 10.3904/kjim.2023.097 | 2023 | ||
| Integrated analysis of the microbiota-gut-brain axis in response to sleep deprivation and diet-induced obesity. | Lee J, Kang J, Kim Y, Lee S, Oh CM, Kim T. | Front Endocrinol (Lausanne) | 10.3389/fendo.2023.1117259 | 2023 | ||
| Comparative Analysis of Fecal Microbiota Composition Between Rheumatoid Arthritis and Osteoarthritis Patients. | Lee JY, Mannaa M, Kim Y, Kim J, Kim GT, Seo YS. | Genes (Basel) | 10.3390/genes10100748 | 2019 | ||
| Eggshell and Feed Microbiota Do Not Represent Major Sources of Gut Anaerobes for Chickens in Commercial Production. | Volf J, Crhanova M, Karasova D, Faldynova M, Kubasova T, Seidlerova Z, Sebkova A, Zeman M, Juricova H, Matiasovicova J, Foltyn M, Tvrdon Z, Rychlik I. | Microorganisms | 10.3390/microorganisms9071480 | 2021 | ||
| Genetics | Feature selection with vector-symbolic architectures: a case study on microbial profiles of shotgun metagenomic samples of colorectal cancer. | Cumbo F, Truglia S, Weitschek E, Blankenberg D. | Brief Bioinform | 10.1093/bib/bbaf177 | 2025 | |
| Efficacy and safety of Bacteroides fragilis BF839 for pediatric autism spectrum disorder: a randomized clinical trial. | Lin CH, Zeng T, Lu CW, Li DY, Liu YY, Li BM, Chen SQ, Deng YH. | Front Nutr | 10.3389/fnut.2024.1447059 | 2024 | ||
| Exploring the regulatory mechanism of intestinal flora based on PD-1 receptor/ligand targeted cancer immunotherapy. | Gao X, Jiang J. | Front Immunol | 10.3389/fimmu.2024.1359029 | 2024 | ||
| Multi-omics analysis reveals regime shifts in the gastrointestinal ecosystem in chickens following anticoccidial vaccination and Eimeria tenella challenge. | Liu P-Y, Liaw J, Soutter F, Ortiz JJ, Tomley FM, Werling D, Gundogdu O, Blake DP, Xia D. | mSystems | 10.1128/msystems.00947-24 | 2024 | ||
| Metabolism | Bacterial and plant HAD enzymes catalyse a missing phosphatase step in thiamin diphosphate biosynthesis. | Hasnain G, Roje S, Sa N, Zallot R, Ziemak MJ, de Crecy-Lagard V, Gregory JF, Hanson AD. | Biochem J | 10.1042/bj20150805 | 2016 | |
| Profile of the Gut Microbiome Containing Carbapenem-Resistant Enterobacteriaceae in ICU Patients. | Sindi AA, Alsayed SM, Abushoshah I, Bokhary DH, Tashkandy NR. | Microorganisms | 10.3390/microorganisms10071309 | 2022 | ||
| Metabolism | In-depth multiomic characterization of the effects of obesity in high-fat diet-fed mice. | Li B, Chen J, Ou X, Liu X, Xu Z, Xiang X, Yang Y, Wang Q. | FEBS Open Bio | 10.1002/2211-5463.13788 | 2024 | |
| Metabolism | Low-dose valine attenuates diet-induced metabolic dysfunction-associated steatotic liver disease (MASLD) in mice by enhancing leptin sensitivity and modulating the gut microbiome. | Felicianna, Lo EKK, Chen C, Ismaiah MJ, Zhang F, Leung HKM, El-Nezami H. | Mol Metab | 10.1016/j.molmet.2024.102059 | 2024 | |
| Gut microbiota diversity and composition in predicting immunotherapy response and immunotherapy-related colitis in melanoma patients: A systematic review. | Oey O, Liu YY, Sunjaya AF, Simadibrata DM, Khattak MA, Gray E. | World J Clin Oncol | 10.5306/wjco.v13.i11.929 | 2022 | ||
| Dietary iron intake has long-term effects on the fecal metabolome and microbiome. | Kostenko A, Zuffa S, Zhi H, Mildau K, Raffatellu M, Dorrestein PC, Aron AT. | Metallomics | 10.1093/mtomcs/mfae033 | 2024 | ||
| Pathogenicity | Microbial-derived imidazole propionate links the heart failure-associated microbiome alterations to disease severity. | Raju SC, Molinaro A, Awoyemi A, Jorgensen SF, Braadland PR, Nendl A, Seljeflot I, Ueland PM, McCann A, Aukrust P, Vestad B, Mayerhofer C, Broch K, Gullestad L, Lappegard KT, Halvorsen B, Kristiansen K, Hov JR, Troseid M. | Genome Med | 10.1186/s13073-024-01296-6 | 2024 | |
| Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis. | Gupta VK, Cunningham KY, Hur B, Bakshi U, Huang H, Warrington KJ, Taneja V, Myasoedova E, Davis JM, Sung J. | Genome Med | 10.1186/s13073-021-00957-0 | 2021 | ||
| Transcriptome | The altered TBI fecal microbiome is stable and functionally distinct. | Pyles RB, Miller AL, Urban RJ, Sheffield-Moore M, Wright TJ, Maxwell CA, Randolph KM, Danesi CP, McGovern KA, Vargas J, Armstrong P, Kreber L, Cumpa G, Randall K, Morrison M, Masel BE. | Front Mol Neurosci | 10.3389/fnmol.2024.1341808 | 2024 | |
| The gut microbiome in end-stage lung disease and lung transplantation. | Zhang S, Swarte JC, Gacesa R, Knobbe TJ, Kremer D, Jansen BH, de Borst MH, TransplantLines Investigators, Harmsen HJM, Erasmus ME, Verschuuren EAM, Bakker SJL, Gan CT, Weersma RK, Bjork JR. | mSystems | 10.1128/msystems.01312-23 | 2024 | ||
| Berberine-microbiota interplay: orchestrating gut health through modulation of the gut microbiota and metabolic transformation into bioactive metabolites. | Dehau T, Cherlet M, Croubels S, Van De Vliet M, Goossens E, Van Immerseel F. | Front Pharmacol | 10.3389/fphar.2023.1281090 | 2023 | ||
| Genetics | Gut microbiota composition and function in pregnancy as determinants of prediabetes at two-year postpartum. | Houttu N, Benchraka C, Lotankar M, Muhli E, Niinikoski H, Lahti L, Laitinen K. | Acta Diabetol | 10.1007/s00592-023-02064-5 | 2023 | |
| Pathogenicity | Impact of 2'-Fucosyllactose on Gut Microbiota Composition in Adults with Chronic Gastrointestinal Conditions: Batch Culture Fermentation Model and Pilot Clinical Trial Findings. | Ryan JJ, Monteagudo-Mera A, Contractor N, Gibson GR. | Nutrients | 10.3390/nu13030938 | 2021 | |
| Metabolism | Composition and functional profiles of gut microbiota reflect the treatment stage, severity, and etiology of acute pancreatitis. | Wang Z, Guo M, Li J, Jiang C, Yang S, Zheng S, Li M, Ai X, Xu X, Zhang W, He X, Wang Y, Chen Y. | Microbiol Spectr | 10.1128/spectrum.00829-23 | 2023 | |
| Insights into the Relationship Between the Gut Microbiome and Immune Checkpoint Inhibitors in Solid Tumors. | Ciernikova S, Sevcikova A, Novisedlakova M, Mego M. | Cancers (Basel) | 10.3390/cancers16244271 | 2024 | ||
| Pathogenicity | The gut microbiome in bullous pemphigoid: implications of the gut-skin axis for disease susceptibility. | Liu X, van Beek N, Cepic A, Andreani NA, Chung CJ, Hermes BM, Yilmaz K, Benoit S, Drenovska K, Gerdes S, Glaser R, Goebeler M, Gunther C, von Georg A, Hammers CM, Holtsche MM, Hubner F, Kiritsi D, Schauer F, Linnenmann B, Huilaja L, Tasanen-Maatta K, Vassileva S, Zillikens D, Sadik CD, Schmidt E, Ibrahim S, Baines JF. | Front Immunol | 10.3389/fimmu.2023.1212551 | 2023 | |
| Impact of Gut Dysbiosis on the Risk of Non-Small-Cell Lung Cancer. | Wei YF, Huang MS, Huang CH, Yeh YT, Hung CH. | Int J Environ Res Public Health | 10.3390/ijerph192315991 | 2022 | ||
| Phylogeny | Identification of acacia gum fermenting bacteria from pooled human feces using anaerobic enrichment culture. | Rawi MH, Tan HY, Sarbini SR. | Front Microbiol | 10.3389/fmicb.2023.1245042 | 2023 | |
| Sarecycline Demonstrated Reduced Activity Compared to Minocycline against Microbial Species Representing Human Gastrointestinal Microbiota. | Ghannoum MA, Long L, Bunick CG, Del Rosso JQ, Gamal A, Tyring SK, McCormick TS, Grada A. | Antibiotics (Basel) | 10.3390/antibiotics11030324 | 2022 | ||
| Gut butyrate-producers confer post-infarction cardiac protection. | Chen HC, Liu YW, Chang KC, Wu YW, Chen YM, Chao YK, You MY, Lundy DJ, Lin CJ, Hsieh ML, Cheng YC, Prajnamitra RP, Lin PJ, Ruan SC, Chen DH, Shih ESC, Chen KW, Chang SS, Chang CMC, Puntney R, Moy AW, Cheng YY, Chien HY, Lee JJ, Wu DC, Hwang MJ, Coonen J, Hacker TA, Yen CE, Rey FE, Kamp TJ, Hsieh PCH. | Nat Commun | 10.1038/s41467-023-43167-5 | 2023 | ||
| Multi-kingdom microbial signatures in excess body weight colorectal cancer based on global metagenomic analysis. | Zhu X, Xu P, Zhu R, Gao W, Yin W, Lan P, Zhu L, Jiao N. | Commun Biol | 10.1038/s42003-023-05714-0 | 2024 | ||
| The oral administration of Lacticaseibacillus casei Shirota alleviates acetaminophen-induced liver injury through accelerated acetaminophen metabolism via the liver-gut axis in mice. | Lv L, Ren S, Jiang H, Yan R, Chen W, Yan R, Dong J, Shao L, Yu Y. | mSphere | 10.1128/msphere.00672-23 | 2024 | ||
| Checkpoint inhibitor responses can be regulated by the gut microbiota - A systematic review. | Zeriouh M, Raskov H, Kvich L, Gogenur I, Bennedsen ALB. | Neoplasia | 10.1016/j.neo.2023.100923 | 2023 | ||
| Single-cell transcriptomics unveiled that early life BDE-99 exposure reprogrammed the gut-liver axis to promote a proinflammatory metabolic signature in male mice at late adulthood. | Lim JJ, Goedken M, Jin Y, Gu H, Cui JY. | Toxicol Sci | 10.1093/toxsci/kfae047 | 2024 | ||
| Fecal microbiota transplantation and its repercussions in patients with melanoma refractory to anti-PD-1 therapy: scope review. | Barbosa EC, Bucar EEC, Jube GR, Silveira LB, Silva NCD, Faria PCC, Ramos PLC, Moraes VRY, Barros JOB. | Rev Col Bras Cir | 10.1590/0100-6991e-20233490-en | 2023 | ||
| Gut feelings: the relations between depression, anxiety, psychotropic drugs and the gut microbiome. | Brushett S, Gacesa R, Vich Vila A, Brandao Gois MF, Andreu-Sanchez S, Swarte JC, Klaassen MAY, Collij V, Sinha T, Bolte LA, Wu J, Swertz M, de Kroon MLA, Reijneveld SA, Wijmenga C, Weersma RK, Fu J, van Loo HM, Kurilshikov A, Zhernakova A. | Gut Microbes | 10.1080/19490976.2023.2281360 | 2023 | ||
| Phylogeny | Gut mucosal microbiota profiles linked to colorectal cancer recurrence. | Huo RX, Wang YJ, Hou SB, Wang W, Zhang CZ, Wan XH. | World J Gastroenterol | 10.3748/wjg.v28.i18.1946 | 2022 | |
| The gut microbiota in multiple sclerosis varies with disease activity. | Thirion F, Sellebjerg F, Fan Y, Lyu L, Hansen TH, Pons N, Levenez F, Quinquis B, Stankevic E, Sondergaard HB, Dantoft TM, Poulsen CS, Forslund SK, Vestergaard H, Hansen T, Brix S, Oturai A, Sorensen PS, Ehrlich SD, Pedersen O. | Genome Med | 10.1186/s13073-022-01148-1 | 2023 | ||
| Probiotic Escherichia coli Nissle 1917 protect chicks from damage caused by Salmonella enterica serovar Enteritidis colonization. | Wu S, Zhang Q, Cong G, Xiao Y, Shen Y, Zhang S, Zhao W, Shi S. | Anim Nutr | 10.1016/j.aninu.2023.06.001 | 2023 | ||
| Pathogenicity | Gut microbiota composition is altered in postural orthostatic tachycardia syndrome and post-acute COVID-19 syndrome. | Hamrefors V, Kahn F, Holmqvist M, Carlson K, Varjus R, Gudjonsson A, Fedorowski A, Ohlsson B. | Sci Rep | 10.1038/s41598-024-53784-9 | 2024 | |
| Clinical Significance of Probiotics for Children with Idiopathic Nephrotic Syndrome. | Yamaguchi T, Tsuji S, Akagawa S, Akagawa Y, Kino J, Yamanouchi S, Kimata T, Hashiyada M, Akane A, Kaneko K. | Nutrients | 10.3390/nu13020365 | 2021 | ||
| Pathogenicity | Dual RNA-seq study of the dynamics of coding and non-coding RNA expression during Clostridioides difficile infection in a mouse model. | Kreis V, Toffano-Nioche C, Deneve-Larrazet C, Marvaud J-C, Garneau JR, Dumont F, van Dijk EL, Jaszczyszyn Y, Boutserin A, D'Angelo F, Gautheret D, Kansau I, Janoir C, Soutourina O. | mSystems | 10.1128/msystems.00863-24 | 2024 | |
| A Survey of Bacterial Microcompartment Distribution in the Human Microbiome. | Asija K, Sutter M, Kerfeld CA. | Front Microbiol | 10.3389/fmicb.2021.669024 | 2021 | ||
| A cross-sectional study identifying disparities in serum metabolic profiles among hypertensive patients with ISH, IDH and SDH subtypes. | Shen Y, Wang P, Yang X, Chen M, Dong Y, Li J. | Front Cardiovasc Med | 10.3389/fcvm.2023.1102754 | 2023 | ||
| Gallstone Disease and Bacterial Metabolic Performance of Gut Microbiota in Middle-Aged and Older Patients. | Georgescu D, Ionita I, Lascu A, Hut EF, Dragan S, Ancusa OE, Ionita M, Calamar-Popovici D, Georgescu LA, Lighezan DF. | Int J Gen Med | 10.2147/ijgm.s350104 | 2022 | ||
| Baseline gut microbiota and metabolome predict durable immunogenicity to SARS-CoV-2 vaccines. | Peng Y, Zhang L, Mok CKP, Ching JYL, Zhao S, Wong MKL, Zhu J, Chen C, Wang S, Yan S, Qin B, Liu Y, Zhang X, Cheung CP, Cheong PK, Ip KL, Fung ACH, Wong KKY, Hui DSC, Chan FKL, Ng SC, Tun HM. | Signal Transduct Target Ther | 10.1038/s41392-023-01629-8 | 2023 | ||
| Immunotherapy in Colorectal Cancer: Potential of Fecal Transplant and Microbiota-augmented Clinical Trials. | Park R, Umar S, Kasi A. | Curr Colorectal Cancer Rep | 10.1007/s11888-020-00456-1 | 2020 | ||
| Fecal transplantation treatment of antibiotic-induced, noninfectious colitis and long-term microbiota follow-up. | Satokari R, Fuentes S, Mattila E, Jalanka J, de Vos WM, Arkkila P. | Case Rep Med | 10.1155/2014/913867 | 2014 | ||
| Gut-resident microorganisms and their genes are associated with cognition and neuroanatomy in children. | Bonham KS, Fahur Bottino G, McCann SH, Beauchemin J, Weisse E, Barry F, Cano Lorente R, RESONANCE Consortium, Huttenhower C, Bruchhage M, D'Sa V, Deoni S, Klepac-Ceraj V. | Sci Adv | 10.1126/sciadv.adi0497 | 2023 | ||
| Gut microbiota: a new player in regulating immune- and chemo-therapy efficacy. | Anfossi S, Calin GA. | Cancer Drug Resist | 10.20517/cdr.2020.04 | 2020 | ||
| Prevotella copri alleviates sarcopenia via attenuating muscle mass loss and function decline. | Liu X, Wu J, Tang J, Xu Z, Zhou B, Liu Y, Hu F, Zhang G, Cheng R, Xia X, Chen Y, Wu H, Wang D, Yue J, Dong B, Fu J, Yu H, Dong B. | J Cachexia Sarcopenia Muscle | 10.1002/jcsm.13313 | 2023 | ||
| Alterations of fecal antibiotic resistome in COVID-19 patients after empirical antibiotic exposure. | Kang Y, Chen S, Chen Y, Tian L, Wu Q, Zheng M, Li Z. | Int J Hyg Environ Health | 10.1016/j.ijheh.2021.113882 | 2022 | ||
| Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study. | Palacios T, Vitetta L, Coulson S, Madigan CD, Lam YY, Manuel R, Briskey D, Hendy C, Kim JN, Ishoey T, Soto-Giron MJ, Schott EM, Toledo G, Caterson ID. | Nutrients | 10.3390/nu12072041 | 2020 | ||
| Enzymology | Identification of mucin degraders of the human gut microbiota. | Raimondi S, Musmeci E, Candeliere F, Amaretti A, Rossi M. | Sci Rep | 10.1038/s41598-021-90553-4 | 2021 | |
| Genetics | Changes in Gut Microbiota of Patients with Atopic Dermatitis During Balneotherapy. | Thirion F, Guilly S, Fromentin S, Plaza Onate F, Alvarez AS, Le Chatelier E, Pons N, Levenez F, Quinquis B, Ehrlich S, Dore J, Martin R, Seite S. | Clin Cosmet Investig Dermatol | 10.2147/ccid.s342104 | 2022 | |
| Genetics | Gut Microbiome Alterations in Patients With Visceral Obesity Based on Quantitative Computed Tomography. | Yan H, Qin Q, Chen J, Yan S, Li T, Gao X, Yang Y, Li A, Ding S. | Front Cell Infect Microbiol | 10.3389/fcimb.2021.823262 | 2021 | |
| Phylogeny | Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. | Nagy-Szakal D, Williams BL, Mishra N, Che X, Lee B, Bateman L, Klimas NG, Komaroff AL, Levine S, Montoya JG, Peterson DL, Ramanan D, Jain K, Eddy ML, Hornig M, Lipkin WI. | Microbiome | 10.1186/s40168-017-0261-y | 2017 | |
| Stochastic block models reveal a robust nested pattern in healthy human gut microbiomes. | Cobo-Lopez S, Gupta VK, Sung J, Guimera R, Sales-Pardo M. | PNAS Nexus | 10.1093/pnasnexus/pgac055 | 2022 | ||
| Genetics | Whole genome sequencing and function prediction of 133 gut anaerobes isolated from chicken caecum in pure cultures. | Medvecky M, Cejkova D, Polansky O, Karasova D, Kubasova T, Cizek A, Rychlik I. | BMC Genomics | 10.1186/s12864-018-4959-4 | 2018 | |
| Phylogeny | The Compromised Mucosal Immune System of beta7 Integrin-Deficient Mice Has Only Minor Effects on the Fecal Microbiota in Homeostasis. | Babbar A, Hitch TCA, Pabst O, Clavel T, Hubel J, Eswaran S, Wagner N, Schippers A. | Front Microbiol | 10.3389/fmicb.2019.02284 | 2019 | |
| Pathogenicity | The development of probiotics and prebiotics therapy to ulcerative colitis: a therapy that has gained considerable momentum. | Guo J, Li L, Cai Y, Kang Y. | Cell Commun Signal | 10.1186/s12964-024-01611-z | 2024 | |
| Pathogenicity | Associations of dietary diversity with the gut microbiome, fecal metabolites, and host metabolism: results from 2 prospective Chinese cohorts. | Xiao C, Wang JT, Su C, Miao Z, Tang J, Ouyang Y, Yan Y, Jiang Z, Fu Y, Shuai M, Gou W, Xu F, Yu EY, Liang Y, Liang X, Tian Y, Wang J, Huang F, Zhang B, Wang H, Chen YM, Zheng JS. | Am J Clin Nutr | 10.1093/ajcn/nqac178 | 2022 | |
| Metabolism | Longitudinal multi-omics analysis uncovers the altered landscape of gut microbiota and plasma metabolome in response to high altitude. | Han Y, Liu X, Jia Q, Xu J, Shi J, Li X, Xie G, Zhao X, He K. | Microbiome | 10.1186/s40168-024-01781-5 | 2024 | |
| Effect of dietary supplementation with Lactobacillus acidophilus D2/CSL (CECT 4529) on caecum microbioma and productive performance in broiler chickens. | De Cesare A, Sirri F, Manfreda G, Moniaci P, Giardini A, Zampiga M, Meluzzi A. | PLoS One | 10.1371/journal.pone.0176309 | 2017 | ||
| Phylogeny | An insight into intestinal mucosal microbiota disruption after stroke. | Stanley D, Moore RJ, Wong CHY. | Sci Rep | 10.1038/s41598-017-18904-8 | 2018 | |
| Zunyimycin C enhances immunity and improves cognitive impairment and its mechanism. | Wang X, Li Z, Sun R, Li X, Guo R, Cui X, Liu B, Li W, Yang Y, Huang X, Qu H, Liu C, Wang Z, Lu Y, Yue C. | Front Cell Infect Microbiol | 10.3389/fcimb.2022.1081243 | 2022 | ||
| Gut microbiota as the key controllers of "healthy" aging of elderly people. | Ragonnaud E, Biragyn A. | Immun Ageing | 10.1186/s12979-020-00213-w | 2021 | ||
| Antibiotic Exposure Aggravates Bacteroides-Linked Uremic Toxicity in the Gut-Kidney Axis. | Ray N, Jeong H, Kwon D, Kim J, Moon Y. | Front Immunol | 10.3389/fimmu.2022.737536 | 2022 | ||
| Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors. | Rezasoltani S, Yadegar A, Asadzadeh Aghdaei H, Reza Zali M. | Cancer Med | 10.1002/cam4.3694 | 2021 | ||
| Pathogenicity | Gut inflammation and dysbiosis in human motor neuron disease. | Rowin J, Xia Y, Jung B, Sun J. | Physiol Rep | 10.14814/phy2.13443 | 2017 | |
| High-throughput Sequencing-based Analysis of the Intestinal Microbiota of Broiler Chickens Fed Genetically Modified Rice Expressing Cry1Ac/Cry1Ab Chimeric Bacillus thuringiensis Protein. | Lili G, Deng X, Minhong Z, Changlong S, Jinghai F, Fuping S, Fan L, Jie Z. | J Poult Sci | 10.2141/jpsa.0170029 | 2018 | ||
| PM2RA: A Framework for Detecting and Quantifying Relationship Alterations in Microbial Community. | Liu Z, Mi K, Xu ZZ, Zhang Q, Liu X. | Genomics Proteomics Bioinformatics | 10.1016/j.gpb.2020.07.005 | 2021 | ||
| The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies. | Gong J, Chehrazi-Raffle A, Placencio-Hickok V, Guan M, Hendifar A, Salgia R. | Clin Transl Med | 10.1186/s40169-019-0225-x | 2019 | ||
| Pathogenicity | Eukaryotic and Prokaryotic Microbiota Interactions. | Kodio A, Menu E, Ranque S. | Microorganisms | 10.3390/microorganisms8122018 | 2020 | |
| Pathogenicity | Eubacterium rectale Attenuates HSV-1 Induced Systemic Inflammation in Mice by Inhibiting CD83. | Islam SMS, Ryu HM, Sayeed HM, Byun HO, Jung JY, Kim HA, Suh CH, Sohn S. | Front Immunol | 10.3389/fimmu.2021.712312 | 2021 | |
| Genetics | Metagenome-wide association study of the alterations in the intestinal microbiome composition of ankylosing spondylitis patients and the effect of traditional and herbal treatment. | Huang R, Li F, Zhou Y, Zeng Z, He X, Fang L, Pan F, Chen Y, Lin J, Li J, Qiu D, Tian Y, Tan X, Song Y, Xu Y, Lai Y, Yi H, Gao Q, Fang X, Shi M, Zhou C, Huang J, He YT. | J Med Microbiol | 10.1099/jmm.0.001107 | 2020 | |
| Metabolism | Microbial Community Evolution Is Significantly Impacted by the Use of Calcium Isosaccharinic Acid as an Analogue for the Products of Alkaline Cellulose Degradation. | Kyeremeh IA, Charles CJ, Rout SP, Laws AP, Humphreys PN. | PLoS One | 10.1371/journal.pone.0165832 | 2016 | |
| Microbiome in Cancer Development and Treatment. | Ciernikova S, Sevcikova A, Mladosievicova B, Mego M. | Microorganisms | 10.3390/microorganisms12010024 | 2023 | ||
| Phylogeny | Imaging the in vivo growth patterns of bacteria in human gut Microbiota. | Lin L, Song J, Li J, Zuo X, Wei H, Yang C, Wang W. | Gut Microbes | 10.1080/19490976.2021.1960134 | 2021 | |
| Candida expansion in the gut of lung cancer patients associates with an ecological signature that supports growth under dysbiotic conditions. | Seelbinder B, Lohinai Z, Vazquez-Uribe R, Brunke S, Chen X, Mirhakkak M, Lopez-Escalera S, Dome B, Megyesfalvi Z, Berta J, Galffy G, Dulka E, Wellejus A, Weiss GJ, Bauer M, Hube B, Sommer MOA, Panagiotou G. | Nat Commun | 10.1038/s41467-023-38058-8 | 2023 | ||
| An online atlas of human plasma metabolite signatures of gut microbiome composition. | Dekkers KF, Sayols-Baixeras S, Baldanzi G, Nowak C, Hammar U, Nguyen D, Varotsis G, Brunkwall L, Nielsen N, Eklund AC, Bak Holm J, Nielsen HB, Ottosson F, Lin YT, Ahmad S, Lind L, Sundstrom J, Engstrom G, Smith JG, Arnlov J, Orho-Melander M, Fall T. | Nat Commun | 10.1038/s41467-022-33050-0 | 2022 | ||
| Cigarette smoking status alters dysbiotic gut microbes in hypertensive patients. | Wang P, Dong Y, Jiao J, Zuo K, Han C, Zhao L, Ding S, Yang X, Chen M, Li J. | J Clin Hypertens (Greenwich) | 10.1111/jch.14298 | 2021 | ||
| Genetics | A metagenome-wide association study of gut microbiome and visceral fat accumulation. | Nie X, Chen J, Ma X, Ni Y, Shen Y, Yu H, Panagiotou G, Bao Y. | Comput Struct Biotechnol J | 10.1016/j.csbj.2020.09.026 | 2020 | |
| Phylogeny | Effect of Lactobacillus acidophilus D2/CSL (CECT 4529) supplementation in drinking water on chicken crop and caeca microbiome. | De Cesare A, Sala C, Castellani G, Astolfi A, Indio V, Giardini A, Manfreda G. | PLoS One | 10.1371/journal.pone.0228338 | 2020 | |
| Pathogenicity | Development of an Index Score for Intestinal Inflammation-Associated Dysbiosis Using Real-World Stool Test Results. | Chen L, Reynolds C, David R, Peace Brewer A. | Dig Dis Sci | 10.1007/s10620-019-05828-8 | 2020 | |
| Pathogenicity | B Cells and Microbiota in Autoimmunity. | Botia-Sanchez M, Alarcon-Riquelme ME, Galicia G. | Int J Mol Sci | 10.3390/ijms22094846 | 2021 | |
| Protective Effect of Lactobacillus plantarum P8 on Growth Performance, Intestinal Health, and Microbiota in Eimeria-Infected Broilers. | Wang Y, Lv X, Li X, Zhao J, Zhang K, Hao X, Liu K, Liu H. | Front Microbiol | 10.3389/fmicb.2021.705758 | 2021 | ||
| Discordance between changes in the gut microbiota and pathogenicity in a mouse model of spontaneous colitis. | Perez-Munoz ME, Bergstrom K, Peng V, Schmaltz R, Jimenez-Cardona R, Marsteller N, McGee S, Clavel T, Ley R, Fu J, Xia L, Peterson DA. | Gut Microbes | 10.4161/gmic.28622 | 2014 | ||
| Pathogenicity | DMARDs-Gut Microbiota Feedback: Implications in the Response to Therapy. | Zaragoza-Garcia O, Castro-Alarcon N, Perez-Rubio G, Guzman-Guzman IP. | Biomolecules | 10.3390/biom10111479 | 2020 | |
| Phylogeny | Bacteraemia caused by Anaerotruncus colihominis and emended description of the species. | Lau SK, Woo PC, Woo GK, Fung AM, Ngan AH, Song Y, Liu C, Summanen P, Finegold SM, Yuen K. | J Clin Pathol | 10.1136/jcp.2005.031773 | 2006 | |
| Mobile genetic elements from the maternal microbiome shape infant gut microbial assembly and metabolism. | Vatanen T, Jabbar KS, Ruohtula T, Honkanen J, Avila-Pacheco J, Siljander H, Strazar M, Oikarinen S, Hyoty H, Ilonen J, Mitchell CM, Yassour M, Virtanen SM, Clish CB, Plichta DR, Vlamakis H, Knip M, Xavier RJ. | Cell | 10.1016/j.cell.2022.11.023 | 2022 | ||
| Metabolism | Gut Microbiota as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation Study. | Wu IW, Lin CY, Chang LC, Lee CC, Chiu CY, Hsu HJ, Sun CY, Chen YC, Kuo YL, Yang CW, Gao SS, Hsieh WP, Chung WH, Lai HC, Su SC. | Int J Biol Sci | 10.7150/ijbs.37421 | 2020 | |
| Genetics | Bacterial community structure alterations within the colorectal cancer gut microbiome. | Loftus M, Hassouneh SA, Yooseph S. | BMC Microbiol | 10.1186/s12866-021-02153-x | 2021 | |
| Pathogenicity | Metformin Strongly Affects Gut Microbiome Composition in High-Fat Diet-Induced Type 2 Diabetes Mouse Model of Both Sexes. | Silamikele L, Silamikelis I, Ustinova M, Kalnina Z, Elbere I, Petrovska R, Kalnina I, Klovins J. | Front Endocrinol (Lausanne) | 10.3389/fendo.2021.626359 | 2021 | |
| Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. | Vallianou N, Christodoulatos GS, Karampela I, Tsilingiris D, Magkos F, Stratigou T, Kounatidis D, Dalamaga M. | Biomolecules | 10.3390/biom12010056 | 2021 | ||
| Genetics | Disorganized Gut Microbiome Contributed to Liver Cirrhosis Progression: A Meta-Omics-Based Study. | Shao L, Ling Z, Chen D, Liu Y, Yang F, Li L. | Front Microbiol | 10.3389/fmicb.2018.03166 | 2018 | |
| Stool microRNA profiles reflect different dietary and gut microbiome patterns in healthy individuals. | Tarallo S, Ferrero G, De Filippis F, Francavilla A, Pasolli E, Panero V, Cordero F, Segata N, Grioni S, Pensa RG, Pardini B, Ercolini D, Naccarati A. | Gut | 10.1136/gutjnl-2021-325168 | 2022 | ||
| Metabolism | Xenometabolite signatures in the UC Davis type 2 diabetes mellitus rat model revealed using a metabolomics platform enriched with microbe-derived metabolites. | Mercer KE, Yeruva L, Pack L, Graham JL, Stanhope KL, Chintapalli SV, Wankhade UD, Shankar K, Havel PJ, Adams SH, Piccolo BD. | Am J Physiol Gastrointest Liver Physiol | 10.1152/ajpgi.00105.2020 | 2020 | |
| Next-generation prebiotic promotes selective growth of bifidobacteria, suppressing Clostridioides difficile. | Hirano R, Sakanaka M, Yoshimi K, Sugimoto N, Eguchi S, Yamauchi Y, Nara M, Maeda S, Ami Y, Gotoh A, Katayama T, Iida N, Kato T, Ohno H, Fukiya S, Yokota A, Nishimoto M, Kitaoka M, Nakai H, Kurihara S. | Gut Microbes | 10.1080/19490976.2021.1973835 | 2021 | ||
| Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer. | Veziant J, Villeger R, Barnich N, Bonnet M. | Cancers (Basel) | 10.3390/cancers13092215 | 2021 | ||
| Shifts in the Gut Microbiota Composition Due to Depleted Bone Marrow Beta Adrenergic Signaling Are Associated with Suppressed Inflammatory Transcriptional Networks in the Mouse Colon. | Yang T, Ahmari N, Schmidt JT, Redler T, Arocha R, Pacholec K, Magee KL, Malphurs W, Owen JL, Krane GA, Li E, Wang GP, Vickroy TW, Raizada MK, Martyniuk CJ, Zubcevic J. | Front Physiol | 10.3389/fphys.2017.00220 | 2017 | ||
| Peeling back the many layers of competitive exclusion. | Maurer JJ, Cheng Y, Pedroso A, Thompson KK, Akter S, Kwan T, Morota G, Kinstler S, Porwollik S, McClelland M, Escalante-Semerena JC, Lee MD. | Front Microbiol | 10.3389/fmicb.2024.1342887 | 2024 | ||
| Pathogenicity | TLR4 May Be Involved in the Regulation of Colonic Mucosal Microbiota by Vitamin A. | Xiao L, Chen B, Feng D, Yang T, Li T, Chen J. | Front Microbiol | 10.3389/fmicb.2019.00268 | 2019 | |
| The oral microbiome and oral and upper gastrointestinal diseases. | Liu S, Wang S, Zhang N, Li P. | J Oral Microbiol | 10.1080/20002297.2024.2355823 | 2024 | ||
| Metabolism | Microbiome and ischemic stroke: A systematic review. | Lee YT, Mohd Ismail NI, Wei LK. | PLoS One | 10.1371/journal.pone.0245038 | 2021 | |
| Influence of Leptin and Adiponectin Supplementation on Intraepithelial Lymphocyte and Microbiota Composition in Suckling Rats. | Grases-Pinto B, Abril-Gil M, Castell M, Rodriguez-Lagunas MJ, Burleigh S, Fak Hallenius F, Prykhodko O, Perez-Cano FJ, Franch A. | Front Immunol | 10.3389/fimmu.2019.02369 | 2019 | ||
| Pathogenicity | Probiotic Lactobacillus plantarum Promotes Intestinal Barrier Function by Strengthening the Epithelium and Modulating Gut Microbiota. | Wang J, Ji H, Wang S, Liu H, Zhang W, Zhang D, Wang Y. | Front Microbiol | 10.3389/fmicb.2018.01953 | 2018 | |
| Pathogenicity | Dietary butyrate glycerides modulate intestinal microbiota composition and serum metabolites in broilers. | Yang X, Yin F, Yang Y, Lepp D, Yu H, Ruan Z, Yang C, Yin Y, Hou Y, Leeson S, Gong J. | Sci Rep | 10.1038/s41598-018-22565-6 | 2018 | |
| Metabolism | Transkingdom interactions between Lactobacilli and hepatic mitochondria attenuate western diet-induced diabetes. | Rodrigues RR, Gurung M, Li Z, Garcia-Jaramillo M, Greer R, Gaulke C, Bauchinger F, You H, Pederson JW, Vasquez-Perez S, White KD, Frink B, Philmus B, Jump DB, Trinchieri G, Berry D, Sharpton TJ, Dzutsev A, Morgun A, Shulzhenko N. | Nat Commun | 10.1038/s41467-020-20313-x | 2021 | |
| Metabolism | 16S rRNA gene profiling and genome reconstruction reveal community metabolic interactions and prebiotic potential of medicinal herbs used in neurodegenerative disease and as nootropics. | Peterson CT, Sharma V, Iablokov SN, Albayrak L, Khanipov K, Uchitel S, Chopra D, Mills PJ, Fofanov Y, Rodionov DA, Peterson SN. | PLoS One | 10.1371/journal.pone.0213869 | 2019 | |
| Metabolism | Paneth cell alpha-defensin misfolding correlates with dysbiosis and ileitis in Crohn's disease model mice. | Shimizu Y, Nakamura K, Yoshii A, Yokoi Y, Kikuchi M, Shinozaki R, Nakamura S, Ohira S, Sugimoto R, Ayabe T. | Life Sci Alliance | 10.26508/lsa.201900592 | 2020 | |
| A comprehensive evaluation of binning methods to recover human gut microbial species from a non-redundant reference gene catalog. | Borderes M, Gasc C, Prestat E, Galvao Ferrarini M, Vinga S, Boucinha L, Sagot MF. | NAR Genom Bioinform | 10.1093/nargab/lqab009 | 2021 | ||
| Metabolism | Characterization of a biogas-producing microbial community by short-read next generation DNA sequencing. | Wirth R, Kovacs E, Maroti G, Bagi Z, Rakhely G, Kovacs KL. | Biotechnol Biofuels | 10.1186/1754-6834-5-41 | 2012 | |
| Genetics | Baseline human gut microbiota profile in healthy people and standard reporting template. | King CH, Desai H, Sylvetsky AC, LoTempio J, Ayanyan S, Carrie J, Crandall KA, Fochtman BC, Gasparyan L, Gulzar N, Howell P, Issa N, Krampis K, Mishra L, Morizono H, Pisegna JR, Rao S, Ren Y, Simonyan V, Smith K, VedBrat S, Yao MD, Mazumder R. | PLoS One | 10.1371/journal.pone.0206484 | 2019 | |
| Metabolism | Diet is a major factor governing the fecal butyrate-producing community structure across Mammalia, Aves and Reptilia. | Vital M, Gao J, Rizzo M, Harrison T, Tiedje JM. | ISME J | 10.1038/ismej.2014.179 | 2015 | |
| Effect of antimicrobial growth promoter administration on the intestinal microbiota of beef cattle. | Reti KL, Thomas MC, Yanke LJ, Selinger LB, Inglis GD. | Gut Pathog | 10.1186/1757-4749-5-8 | 2013 | ||
| Metabolism | Interactions between Roseburia intestinalis and diet modulate atherogenesis in a murine model. | Kasahara K, Krautkramer KA, Org E, Romano KA, Kerby RL, Vivas EI, Mehrabian M, Denu JM, Backhed F, Lusis AJ, Rey FE. | Nat Microbiol | 10.1038/s41564-018-0272-x | 2018 | |
| IspH-RPS1 and IspH-UbiA: "Rosetta Stone" Proteins. | Rao G, O'Dowd B, Li J, Wang K, Oldfield E. | Chem Sci | 10.1039/c5sc02600h | 2015 | ||
| Phylogeny | Host contributes to longitudinal diversity of fecal microbiota in swine selected for lean growth. | Lu D, Tiezzi F, Schillebeeckx C, McNulty NP, Schwab C, Shull C, Maltecca C. | Microbiome | 10.1186/s40168-017-0384-1 | 2018 | |
| Genetics | Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. | Biagi E, Nylund L, Candela M, Ostan R, Bucci L, Pini E, Nikkila J, Monti D, Satokari R, Franceschi C, Brigidi P, De Vos W. | PLoS One | 10.1371/journal.pone.0010667 | 2010 | |
| Metabolism | Distinct signatures of host-microbial meta-metabolome and gut microbiome in two C57BL/6 strains under high-fat diet. | Walker A, Pfitzner B, Neschen S, Kahle M, Harir M, Lucio M, Moritz F, Tziotis D, Witting M, Rothballer M, Engel M, Schmid M, Endesfelder D, Klingenspor M, Rattei T, Castell WZ, de Angelis MH, Hartmann A, Schmitt-Kopplin P. | ISME J | 10.1038/ismej.2014.79 | 2014 | |
| Enzymology | Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. | Van den Abbeele P, Belzer C, Goossens M, Kleerebezem M, De Vos WM, Thas O, De Weirdt R, Kerckhof FM, Van de Wiele T. | ISME J | 10.1038/ismej.2012.158 | 2013 | |
| Metabolism | Weight gain in anorexia nervosa does not ameliorate the faecal microbiota, branched chain fatty acid profiles, and gastrointestinal complaints. | Mack I, Cuntz U, Gramer C, Niedermaier S, Pohl C, Schwiertz A, Zimmermann K, Zipfel S, Enck P, Penders J. | Sci Rep | 10.1038/srep26752 | 2016 | |
| Phylogeny | Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. | Jalanka-Tuovinen J, Salonen A, Nikkila J, Immonen O, Kekkonen R, Lahti L, Palva A, de Vos WM. | PLoS One | 10.1371/journal.pone.0023035 | 2011 | |
| Genetics | Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. | Zupancic ML, Cantarel BL, Liu Z, Drabek EF, Ryan KA, Cirimotich S, Jones C, Knight R, Walters WA, Knights D, Mongodin EF, Horenstein RB, Mitchell BD, Steinle N, Snitker S, Shuldiner AR, Fraser CM. | PLoS One | 10.1371/journal.pone.0043052 | 2012 | |
| Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome. | Ussar S, Griffin NW, Bezy O, Fujisaka S, Vienberg S, Softic S, Deng L, Bry L, Gordon JI, Kahn CR. | Cell Metab | 10.1016/j.cmet.2015.07.007 | 2015 | ||
| Pathogenicity | Perturbation dynamics of the rumen microbiota in response to exogenous butyrate. | Li RW, Wu S, Baldwin RL, Li W, Li C. | PLoS One | 10.1371/journal.pone.0029392 | 2012 | |
| Pathogenicity | Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. | Chang CJ, Lin CS, Lu CC, Martel J, Ko YF, Ojcius DM, Tseng SF, Wu TR, Chen YY, Young JD, Lai HC. | Nat Commun | 10.1038/ncomms8489 | 2015 | |
| Metabolism | Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependent. | Crost EH, Tailford LE, Le Gall G, Fons M, Henrissat B, Juge N. | PLoS One | 10.1371/journal.pone.0076341 | 2013 | |
| CD4CD8alphaalpha lymphocytes, a novel human regulatory T cell subset induced by colonic bacteria and deficient in patients with inflammatory bowel disease. | Sarrabayrouse G, Bossard C, Chauvin JM, Jarry A, Meurette G, Quevrain E, Bridonneau C, Preisser L, Asehnoune K, Labarriere N, Altare F, Sokol H, Jotereau F. | PLoS Biol | 10.1371/journal.pbio.1001833 | 2014 | ||
| Metabolism | Insights into the evolution of sialic acid catabolism among bacteria. | Almagro-Moreno S, Boyd EF. | BMC Evol Biol | 10.1186/1471-2148-9-118 | 2009 | |
| Heterologous Expression and Characterization of Cellouronate (beta-1,4-Glucuronan) Lyase from a Human Intestinal Bacterium Bacteroides luhongzhouii. | Tanaka Y, Matsumura K, Ariga M, Konno N, Ogata M, Habu N. | J Appl Glycosci (1999) | 10.5458/jag.7203102 | 2025 | ||
| Clostridium butyricum-altered lung microbiome is associated with enhanced anti-influenza effects via G-protein-coupled receptor120. | Hagihara M, Yamashita M, Ariyoshi T, Minemura A, Yoshida C, Higashi S, Oka K, Takahashi M, Ota A, Maenaka A, Iwasaki K, Hirai J, Shibata Y, Umemura T, Mori T, Kato H, Asai N, Mikamo H. | iScience | 10.1016/j.isci.2025.113502 | 2025 | ||
| Development of culture methods capable of culturing a wide range of predominant species of intestinal bacteria. | Hirano R, Nishita I, Nakai R, Bito A, Sasabe R, Kurihara S. | Front Cell Infect Microbiol | 10.3389/fcimb.2023.1056866 | 2023 | ||
| Carotenoid productivity in human intestinal bacteria Eubacterium limosum and Leuconostoc mesenteroides with functional analysis of their carotenoid biosynthesis genes. | Matsumoto W, Takemura M, Nanaura H, Ami Y, Maoka T, Shindo K, Kurihara S, Misawa N. | Eng Microbiol | 10.1016/j.engmic.2024.100147 | 2024 | ||
| Cornuside Alleviates Diabetes Mellitus-Induced Testicular Damage by Modulating the Gut Microbiota. | Liu L, Shu A, Zhu Y, Chen Y | Evid Based Complement Alternat Med | 10.1155/2021/5301942 | 2021 | ||
| Pathogenicity | Sodium Butyrate Attenuated Diabetes-Induced Intestinal Inflammation by Modulating Gut Microbiota. | Liu L, Chen Y, Wu Q, Shu A, Sun J | Evid Based Complement Alternat Med | 10.1155/2022/4646245 | 2022 | |
| Genetics | 'Urmitella timonensis' gen. nov., sp. nov., 'Blautia marasmi' sp. nov., 'Lachnoclostridium pacaense' sp. nov., 'Bacillus marasmi' sp. nov. and 'Anaerotruncus rubiinfantis' sp. nov., isolated from stool samples of undernourished African children. | Pham TP, Cadoret F, Alou MT, Brah S, Diallo BA, Diallo A, Sokhna C, Delerce J, Fournier PE, Million M, Raoult D. | New Microbes New Infect | 10.1016/j.nmni.2017.02.004 | 2017 | |
| 'Marasmitruncus massiliensis' gen. nov., sp. nov., 'Clostridium culturomicum' sp. nov., 'Blautia provencensis' sp. nov., 'Bacillus caccae' sp. nov. and 'Ornithinibacillus massiliensis' sp. nov., isolated from stool samples of undernourished African children. | Pham TP, Cadoret F, Tidjani Alou M, Brah S, Ali Diallo B, Diallo A, Sokhna C, Delerce J, Fournier PE, Million M, Raoult D. | New Microbes New Infect | 10.1016/j.nmni.2017.05.005 | 2017 | ||
| Phylogeny | Paludicola psychrotolerans gen. nov., sp. nov., a novel psychrotolerant chitinolytic anaerobe of the family Ruminococcaceae. | Li Y, Zhang LL, Liu L, Tian YQ, Liu XF, Li WJ, Dai YM | Int J Syst Evol Microbiol | 10.1099/ijsem.0.002260 | 2017 | |
| Phylogeny | Harryflintia acetispora gen. nov., sp. nov., isolated from chicken caecum. | Petzoldt D, Breves G, Rautenschlein S, Taras D | Int J Syst Evol Microbiol | 10.1099/ijsem.0.001317 | 2016 | |
| Phylogeny | Anaerotruncus colihominis gen. nov., sp. nov., from human faeces. | Lawson PA, Song Y, Liu C, Molitoris DR, Vaisanen ML, Collins MD, Finegold SM | Int J Syst Evol Microbiol | 10.1099/ijs.0.02653-0 | 2004 | |
| Phylogeny | Anaerotruncus massiliensis sp. nov., a succinate-producing bacterium isolated from human stool from an obese patient after bariatric surgery. | Togo AH, Diop A, Dubourg G, Khelaifia S, Richez M, Armstrong N, Maraninchi M, Fournier PE, Raoult D, Million M | New Microbes New Infect | 10.1016/j.nmni.2019.01.004 | 2019 | |
| Phylogeny | Draft genomes and descriptions of Urmitella timonensis gen. nov., sp. nov. and Marasmitruncus massiliensis gen. nov., sp. nov., isolated from severely malnourished African children using culturomics. | Bellali S, Haddad G, Pham TP, Iwaza R, Ibrahim A, Armstrong N, Fadlane A, Couderc C, Diallo A, Sokhna C, Million M, Raoult D, Tidjani Alou M | Antonie Van Leeuwenhoek | 10.1007/s10482-022-01777-x | 2022 |
| #6848 | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH ; Curators of the DSMZ; DSM 17241 |
| #20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.: List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ. IJSEM ( DOI 10.1099/ijsem.0.004332 ) |
| #26285 | IJSEM 413 2004 ( DOI 10.1099/ijs.0.02653-0 , PubMed 15023953 ) |
| #29914 | Barberan A, Caceres Velazquez H, Jones S, Fierer N.: Hiding in Plain Sight: Mining Bacterial Species Records for Phenotypic Trait Information. mSphere 2: 2017 ( DOI 10.1128/mSphere.00237-17 , PubMed 28776041 ) - originally annotated from #26285 |
| #33163 | ; Curators of the CIP; |
| #56619 | Culture Collection University of Gothenburg (CCUG) ; Curators of the CCUG; CCUG 45055 |
| #66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann: Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) . |
| #66794 | Antje Chang, Lisa Jeske, Sandra Ulbrich, Julia Hofmann, Julia Koblitz, Ida Schomburg, Meina Neumann-Schaal, Dieter Jahn, Dietmar Schomburg: BRENDA, the ELIXIR core data resource in 2021: new developments and updates. Nucleic Acids Res. 49: D498 - D508 2020 ( DOI 10.1093/nar/gkaa1025 , PubMed 33211880 ) |
| #67770 | Japan Collection of Microorganism (JCM) ; Curators of the JCM; |
| #68380 | Automatically annotated from API rID32A . |
| #68382 | Automatically annotated from API zym . |
| #69479 | João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.: MicrobeAtlas 1.0 beta . |
| #118701 | Collection of Institut Pasteur ; Curators of the CIP; CIP 107754 |
| #124043 | Isabel Schober, Julia Koblitz: Data extracted from sequence databases, automatically matched based on designation and taxonomy . |
| #125438 | Julia Koblitz, Lorenz Christian Reimer, Rüdiger Pukall, Jörg Overmann: Predicting bacterial phenotypic traits through improved machine learning using high-quality, curated datasets. 2024 ( DOI 10.1101/2024.08.12.607695 ) |
| #125439 | Philipp Münch, René Mreches, Martin Binder, Hüseyin Anil Gündüz, Xiao-Yin To, Alice McHardy: deepG: Deep Learning for Genome Sequence Data. R package version 0.3.1 . |
| #126262 | A. Lissin, I. Schober, J. F. Witte, H. Lüken, A. Podstawka, J. Koblitz, B. Bunk, P. Dawyndt, P. Vandamme, P. de Vos, J. Overmann, L. C. Reimer: StrainInfo—the central database for linked microbial strain identifiers. ( DOI 10.1093/database/baaf059 ) |
You found an error in BacDive? Please tell us about it!
Note that changes will be reviewed and judged. If your changes are legitimate, changes will occur within the next BacDive update. Only proposed changes supported by the according reference will be reviewed. The BacDive team reserves the right to reject proposed changes.
Successfully sent
If you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive17679.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data